These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31417928)

  • 1. Cost-analysis of inpatient and outpatient parenteral antimicrobial therapy in orthopaedics: A systematic literature review.
    Boese CK; Lechler P; Frink M; Hackl M; Eysel P; Ries C
    World J Clin Cases; 2019 Jul; 7(14):1825-1836. PubMed ID: 31417928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
    Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry.
    Martone WJ; Lindfield KC; Katz DE
    Int J Clin Pract; 2008 Aug; 62(8):1183-7. PubMed ID: 18705821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs.
    Staples JA; Ho M; Ferris D; Hayek J; Liu G; Tran KC; Sutherland JM
    Clin Infect Dis; 2022 Nov; 75(11):1921-1929. PubMed ID: 35439822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Outpatient Parenteral Antimicrobial Therapy (OPAT) in Patients with Complicated Periprosthetic Joint Infections.
    Strassburg A; Weber AT; Kluba T
    Z Orthop Unfall; 2024 May; ():. PubMed ID: 38802072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost analysis of inpatient versus outpatient intravenous antibiotic treatment for periprosthetic joint infections : A simulation].
    Boese CK; Lechler P; Frink M; Hackl M; Eysel P; Ries C
    Orthopade; 2021 Feb; 50(2):150-158. PubMed ID: 32076752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review.
    Psaltikidis EM; Silva END; Bustorff-Silva JM; Moretti ML; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2017 Aug; 17(4):355-375. PubMed ID: 28776441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.
    Dimitrova M; Gilchrist M; Seaton RA
    BMJ Open; 2021 Sep; 11(9):e049733. PubMed ID: 34588251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cost-effectiveness, safety and acceptability of
    Mitchell ED; Czoski Murray C; Meads D; Minton J; Wright J; Twiddy M
    BMJ Open; 2017 Apr; 7(4):e013560. PubMed ID: 28428184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.
    Adams JW; Savinkina A; Hudspeth JC; Gai MJ; Jawa R; Marks LR; Linas BP; Hill A; Flood J; Kimmel S; Barocas JA
    JAMA Netw Open; 2022 Feb; 5(2):e220541. PubMed ID: 35226078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
    Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
    J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
    Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
    Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient parenteral antibiotic therapy for the treatment of prosthetic knee and hip infections in Belgium, a cost minimization analysis.
    Debaenst N; Seyler L; Putman K; Van Den Borre I; Vanlauwe J
    Acta Clin Belg; 2022 Feb; 77(1):10-17. PubMed ID: 32484406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C; Fisher DA; Sklar GE; Li SC
    Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.
    Heintz BH; Halilovic J; Christensen CL
    Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Cost Comparison of Ertapenem as Outpatient Parenteral Antimicrobial Therapy in Acute Pyelonephritis due to Extended-spectrum Beta-lactamase-producing
    Ramasubramanian V; Murlidharan P; Nambi S; Pavithra S; Puthran S; Petigara T
    Indian J Nephrol; 2018; 28(5):351-357. PubMed ID: 30270995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.